Literature DB >> 2042465

Immobilization increases bone prostaglandin E. Effect of acetylsalicylic acid on disuse osteoporosis studied in dogs.

D J Waters1, D D Caywood, G J Trachte, R T Turner, S F Hodgson.   

Abstract

The effect of acetylsalicylic acid (aspirin) on bone mass and bone prostaglandin E (PGE) in immobilization osteoporosis was studied in 12 growing dogs using a unilateral hind limb cast-fixation model. Osteoporosis was induced by fiberglass-cast immobilization of the right hind limb for 4 weeks, with the left hind limb as a control. Six dogs received buffered aspirin at 25 mg/kg body weight per os every 8 hours; 6 dogs received no treatment. All the dogs were killed after 4 weeks, and bone samples were collected. Bone mineral content of the distal tibial metaphysis was measured by single-photon absorptiometry. In vitro release of PGE from the calcaneus, tibial cortical bone, tibial cancellous bone, and ilium were measured using a specific radioimmunoassay for PGE. Compared with the controls, the casted limb of untreated dogs had half the bone mass and a twofold increase in bone PGE. Aspirin treatment was associated with a 65 percent reduction in bone PGE and a 13 percent bone mass sparing effect. These results provide indirect evidence that PGE plays a role in immobilization osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042465     DOI: 10.3109/17453679108993600

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  3 in total

Review 1.  Prostaglandins: mechanisms of action and regulation of production in bone.

Authors:  L G Raisz; C C Pilbeam; P M Fall
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 2.  A Review on the Relationship between Aspirin and Bone Health.

Authors:  Kok-Yong Chin
Journal:  J Osteoporos       Date:  2017-01-09

Review 3.  Ageing: Is there a role for arachidonic acid and other bioactive lipids? A review.

Authors:  Undurti N Das
Journal:  J Adv Res       Date:  2018-02-15       Impact factor: 10.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.